Arvee Laboratories (India) Ltd. (NSE:ARVEE)
India · Delayed Price · Currency is INR 168.72
-8.52 (-4.81%)
Aug 13, 2026, 3:30 PM IST
NSE:ARVEE Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 412.72 | 315.14 | 384.87 | 303.45 | 613.47 | 399.65 |
Revenue Growth | 16.70% | -18.12% | 26.83% | -50.53% | 53.50% | -15.64% |
Gross Profit Gross Profit Growth | 187.82 | 168.5 | 178.02 | 156.43 | 218.99 | 175.25 |
Operating Income Operating Income Growth | 41.2 | 19.84 | 24.62 | 14.39 | 52.02 | 29.94 |
Net Income Net Income Growth | 40.51 | 25.26 | 21.47 | 10.52 | 41.19 | 25.74 |
Earnings Per Share EPS Growth | 3.70 | 2.29 | 1.95 | 0.95 | 3.74 | 2.34 |
EPS Growth | 197.35% | 17.52% | 105.11% | -74.58% | 60.04% | -25.64% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Chemicals Chemicals Growth | - | 384.87 | 303.45 | 613.47 | 399.65 |
Textile Segment Textile Segment Growth | 46.16 | - | - | - | - |
Non-Textile Segment Non-Textile Segment Growth | 275.79 | - | - | - | - |
Total Total Growth | 321.95 | 384.87 | 303.45 | 613.47 | 399.65 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 32.82 | 32.82 | 49.06 | 18.65 | 8.92 | 31.03 |
Total Debt Total Debt Growth | 11.14 | 11.14 | 10.33 | 10 | 10 | 31.31 |
Net Cash (Debt) Net Cash Growth | 21.69 | 21.69 | 38.73 | 8.65 | -1.08 | -0.28 |
Net Cash Growth | -56.11% | -44.00% | 347.50% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.98 | 1.97 | 3.51 | 0.79 | -0.10 | -0.03 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | -1.2 | -2.06 | 36.64 | 29.29 | 6.81 |
Capital Expenditures CapEx Growth | - | -28.33 | -18.54 | -25.86 | -14.84 | -23.64 |
Free Cash Flow Free Cash Flow Growth | - | -29.53 | -20.6 | 10.78 | 14.45 | -16.83 |
Free Cash Flow Growth | - | - | - | -25.41% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 45.51% | 53.47% | 46.25% | 51.55% | 35.70% | 43.85% |
Operating Margin | 9.98% | 6.30% | 6.40% | 4.74% | 8.48% | 7.49% |
Pretax Margin | 11.01% | 7.71% | 7.46% | 6.03% | 10.05% | 8.63% |
Profit Margin | 9.82% | 8.02% | 5.58% | 3.47% | 6.71% | 6.44% |
FCF Margin | - | -9.37% | -5.35% | 3.55% | 2.35% | -4.21% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 45.66 | 58.39 | 72.87 | 150.24 | 23.54 | 48.68 |
P/FCF Ratio | - | - | - | 146.63 | 67.12 | - |
PS Ratio | 4.51 | 4.68 | 4.07 | 5.21 | 1.58 | 3.14 |